No connection

Search Results

AMBQ

BEARISH
$25.36 Live
Ambiq Micro, Inc. · NYSE
Target $38.75 (+52.8%)
$22.12 52W Range $51.76

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Mar 14, 2026
Market cap
$531.38M
P/E
N/A
ROE
-29.4%
Profit margin
-50.3%
Debt/Equity
0.0
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
AMBQ exhibits severe financial distress signals, with a Piotroski F-Score of 1/9 indicating extreme operational weakness and no Altman Z-Score available, raising unquantified bankruptcy risk. Despite a strong gross margin of 44.26%, the company reports deep losses across all profitability metrics, including a -50.28% net profit margin and negative ROE/ROA. Insider selling of $0.55M in the last 6 months, coupled with a 34.2% decline over the past year, underscores deteriorating sentiment. While earnings surprises have been positive in recent quarters, they stem from shrinking losses rather than real profitability, and revenue growth is negligible at just 2% YoY. The stock trades at a premium valuation (Price/Sales: 7.33) despite negative earnings and no intrinsic value support.

Key Strengths

Strong gross margin of 44.26% indicates efficient production or product pricing
Positive earnings surprises in 3 of last 4 quarters suggest better-than-expected cost control or execution
No debt (Debt/Equity: 0.00) provides a clean balance sheet and eliminates interest risk
High current and quick ratios (8.76 and 7.69) indicate strong short-term liquidity
Analyst consensus is 'buy' with a target price of $38.75, implying upside potential

Key Risks

Piotroski F-Score of 1/9 signals severe financial distress and operational failure
Negative profitability across all metrics: net margin -50.28%, ROE -29.38%, ROA -17.11%
Forward P/E of -22.00 reflects continued losses and lack of earnings sustainability
Insider selling of $0.55M in 6 months, including a CTO, indicates internal skepticism
Stock has declined 34.2% over 1 year, 6 months, and 5 years, signaling persistent underperformance

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
21
Weak
Value
20
Future
40
Past
30
Health
15
Dividend
0
AI Verdict
weak
Key drivers: Piotroski F-Score of 1/9, Negative profitability and earnings, High valuation relative to earnings, Declining price trend, Insider selling
Confidence
85%
Value
20/100

Stock trades at a premium valuation despite negative earnings and no intrinsic value support; premium justified only by speculative growth expectations.

Positives
  • Price/Sales of 7.33 is below sector average (avg: 90.93 P/E, but no direct PS comparison)
  • No debt provides valuation stability
Watchpoints
  • No Graham Number or intrinsic value due to negative earnings
  • Forward P/E of -22.00 implies no earnings to value
  • Price/Sales of 7.33 is high for a loss-making company
  • No cash flow or FCF data to support valuation
Future
40/100

Growth expectations are minimal; upside is speculative and not supported by fundamentals.

Positives
  • Recent earnings surprises of up to 70.5% suggest potential for better-than-expected performance
  • Analyst target price of $38.75 implies 53% upside from current price
Watchpoints
  • Revenue growth is only 2.00% YoY, indicating stagnation
  • Most recent Q/Q EPS growth is -45.5%, showing worsening profitability
  • No forward guidance or growth catalysts evident
Past
30/100

Historical performance shows persistent underperformance and declining investor confidence despite short-term earnings beats.

Positives
  • 3 of last 4 quarters beat earnings estimates
  • Improving trend in earnings surprises (from -70.5% to +16.6%)
Watchpoints
  • Consistently negative earnings across all periods
  • 52-week high of $51.76 vs current $25.36 indicates significant decline
  • 5-year, 3-year, 1-year, and 6-month returns all down 34.2% to 44.7%
Health
15/100

Despite strong liquidity, the company is unprofitable and failing on core operational metrics, with Piotroski F-Score signaling high risk of failure.

Positives
  • Debt/Equity of 0.00 indicates no leverage risk
  • Current and quick ratios are extremely high (8.76 and 7.69), indicating strong liquidity
Watchpoints
  • Piotroski F-Score of 1/9 is the lowest possible, indicating severe financial distress
  • Negative ROE, ROA, and ROIC suggest capital is not being deployed effectively
  • No Altman Z-Score available, but the financial profile suggests distress risk
Dividend
0/100

No dividend policy exists; company is loss-making and cannot afford dividends.

Positives
No standout positives identified.
Watchpoints
  • No dividend yield or payout ratio
  • Dividend strength is 0/100
  • Company is not distributing profits, and cannot due to losses

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$25.36
Analyst Target
$38.75
Upside/Downside
+52.8%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for AMBQ and closest competitors.

Updated 2026-03-13
AMB
Ambiq Micro, Inc.
Primary
5Y
-34.2%
3Y
-34.2%
1Y
-34.2%
6M
-26.4%
1M
-13.5%
1W
-10.7%
HKD
AMTD Digital Inc.
Peer
5Y
-89.6%
3Y
-79.9%
1Y
-19.5%
6M
-4.5%
1M
+12.7%
1W
-6.1%
MLA
Mesa Laboratories, Inc.
Peer
5Y
-61.0%
3Y
-39.5%
1Y
-13.6%
6M
+43.8%
1M
+25.5%
1W
+3.8%
CIN
CI&T Inc.
Peer
5Y
-76.7%
3Y
+5.8%
1Y
-20.3%
6M
-14.7%
1M
-12.6%
1W
-10.8%
RDV
Red Violet, Inc.
Peer
5Y
+90.6%
3Y
+145.8%
1Y
+7.3%
6M
-23.2%
1M
-0.5%
1W
+11.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
-22.0
PEG Ratio
N/A
P/B Ratio
2.86
P/S Ratio
7.33
EV/Revenue
5.51
EV/EBITDA
-12.36
Market Cap
$531.38M

Profitability

Profit margins and return metrics

Profit Margin -50.28%
Operating Margin -57.66%
Gross Margin 44.26%
ROE -29.38%
ROA -17.11%

Growth

Revenue and earnings growth rates

Revenue Growth +2.0%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.0
Low debt
Current Ratio
8.76
Strong
Quick Ratio
7.69
Excellent
Cash/Share
$6.6

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q3 2025

Revenue
$0.0B
Gross Margin
42.3%
Op. Margin
-55.3%
Net Margin
-49.6%
Total Assets
$0.2B
Liabilities
$0.0B
Equity
$0.2B
Debt/Equity
0.10x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
134%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-05
$N/A
2026-03-05
$-0.32
+16.6% surprise
2025-11-06
$-0.22
+30.1% surprise
2025-09-04
$-0.13
+70.5% surprise

Technology Sector Comparison

Comparing AMBQ against 565 companies in the Technology sector (45 bullish, 197 neutral, 323 bearish)
Return on Equity (ROE)
-29.38%
This Stock
vs
-33.47%
Sector Avg
-12.2% (Below Avg)
Profit Margin
-50.28%
This Stock
vs
-11.75%
Sector Avg
+328.0% (Superior)
Debt to Equity
0.0
This Stock
vs
0.74
Sector Avg
-99.4% (Less Debt)
Revenue Growth
2.0%
This Stock
vs
4383.21%
Sector Avg
-100.0% (Slower)
Current Ratio
8.76
This Stock
vs
3.59
Sector Avg
+144.2% (Stronger)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

WINZELER JEFFREY G
Chief Financial Officer
Stock Award
2026-03-06
41,728 shares
ESAKA FUMIHIDE
Chief Executive Officer
Stock Award
2026-03-06
160,616 shares
HANSON SCOTT MCLEAN PH.D.
Chief Technology Officer
Stock Award
2026-03-06
80,308 shares
CHEN SEAN CHIHHSIANG
President
Stock Award
2026-03-06
64,246 shares
HSIEH WEN HSUAN
Director
Option Exercise
2026-02-18
238,931 shares · $3,010,531
TAUTGES JOSEPH A
Director
Sell
2026-01-26
7,800 shares · $241,800
HANSON SCOTT MCLEAN PH.D.
Chief Technology Officer
Sell
2026-01-26
10,000 shares · $310,000
ESAKA FUMIHIDE
Chief Executive Officer
Option Exercise
2025-10-07
53,660 shares · $315,521
WINZELER JEFFREY G
Chief Financial Officer
Stock Award
2025-10-02
52,667 shares
ESAKA FUMIHIDE
Chief Executive Officer
Stock Award
2025-10-02
159,907 shares
HANSON SCOTT MCLEAN PH.D.
Chief Financial Officer
Stock Award
2025-10-02
83,819 shares
CHEN SEAN CHIHHSIANG
President
Stock Award
2025-10-02
56,029 shares
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
4 analysts
UBS
2025-10-27
Maintains
Neutral Neutral

Past News Coverage

Recent headlines mentioning AMBQ from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile